基因敲除动物的研究和应用

目的基因敲除动物是近十几年来发展起来的在个体水平上研究基因功能的一类实验动物,它以基因敲除技术和胚胎干细胞技术为基础,在生命科学研究的各个领域得到了广泛应用。最近两年发展起来的RNA干扰技术仍然不能代替它。本文综述了基因敲除动物在各医学生物领域的研究与应用、浅谈其与RNA干扰技术的比较及其发展前景。     

抑制MTM1表达促进胚胎干细胞分化

应用随机RNAi文库,筛选了与胚胎干细胞自我更新和分化调控相关基因,发现了多个阳性候选基因,对其中的1个阳性候选基因肌管素1（myotubularin, MTM1）基因进行了深入研究．MTM1是属于蛋白酪氨酸磷酸酶（PTPase）蛋白家族的蛋白,其基因突变导致肌管性肌病．MTM1在胚胎干细胞中的功能到目前为止还不清楚．研究证实,MTM1在小鼠胚胎干细胞系CCE和R1均有表达．应用RNA干扰及集落形成实验证明,MTM1表达抑制后,处于自我更新状况胚胎干细胞集落的比例显著增加,提示MTM1在胚胎干细胞自我更新和分化的调控中起了重要的作用．     

LincRNA1230抑制小鼠胚胎干细胞向神经前体细胞分化

胚胎干细胞是一类具有多向分化潜能的细胞.胚胎干细胞可以模拟体内发育过程,在无外界信号分子刺激的情况下,自发向神经前体细胞分化.有研究表明,这一体外发育过程受神经分化相关转录因子和表观遗传修饰的共同调控,然而该过程中的分子机制尚不清楚.本研究发现长链非编码RNA1230(LincRNA1230)参与了小鼠(Mus musculus)胚胎干细胞向神经前体细胞的分化过程.在小鼠的胚胎干细胞中过表达LincRNA1230可以显著抑制其神经分化效率;反之,干扰LincRNA1230可以提高分化效率.进一步研究表明,LincRNA1230通过结合Wdr5,降低神经分化相关基因启动子区H3K4me3的修饰水平,从而抑制相关基因的表达活性.这些发现揭示了LincRNA1230在小鼠胚胎干细胞神经分化过程中的重要作用.     

小鼠胚胎干细胞定向分化为神经干细胞过程中microRNA的变化

目的用生物芯片技术分析胚胎干细胞定向分化为神经干细胞过程中microRNA(miRNA)的表达变化,筛选调控的分化的miRNA,研究分化调控机制。方法胚胎干细胞在含LIF培养基中培养3d后,采用经典5步培养方法定向诱导向神经干细胞分化,采用nestin作为神经干细胞标记进行鉴定,送检胚胎干细胞及神经干细胞,提取总RNA以及小分子RNA,经荧光标记后与miRNA基因芯片杂交,获得胚胎干细胞诱导前后miRNA表达谱。结果1)胚胎干细胞在含LIF培养过程中保持未分化状态,Oct-4、碱性磷酸酶表达阳性;2)经典五步法诱导胚胎干细胞定向分化为神经干细胞,nestin阳性细胞为85%;3)通过基因微阵列分析,有90个miRNA的改变显著,其中68个表达上调,22个表达下调。结论miRNA可能对胚胎干细胞定向分化为神经干细胞过程起到关键作用。     

干细胞理论及研究进展

干细胞是目前细胞工程研究最活跃的领域,通过对各种干细胞的界定,胚胎干细胞和成体干细胞的比较研究、以及干细胞的技术应用,揭示出干细胞尤其是胚胎干细胞在医学以及整个生命科学中的巨大潜势,乃至于引发医学领域的重大变革。     

胚胎干细胞相关的MicroRNA研究进展

MicroRNA是一系列高度保守的长度约为22个核苷酸的非编码小分子RNA。这类小分子通过促进mRNA降解或抑制蛋白翻译来调节目的基因的表达。研究表明,MicroRNA在胚胎干细胞中起着重要的调节作用。本文主要阐述MicroRNA在胚胎干细胞干性维持和分化中的调控作用及其机制,就胚胎干细胞相关的MicroRNA研究新进展予以综述和讨论。     

胚胎干细胞分化过程中的表观遗传调控

作为一类既有自我更新能力,并具有多向分化潜能的细胞,胚胎干细胞具有非常重要的理论研究意义和临床应用前景。近期以胚胎干细胞为模型,研究有关干细胞分化的表观遗传调控已成为新的研究热点。本文就胚胎干细胞分化过程中DNA甲基化、组蛋白修饰、非编码RNA调控以及与胚胎干细胞分化密切相关的表观遗传学动态变化做一概述,对表观遗传学改变与胚胎干细胞分化关系的基础研究进行探讨。     

你愿意捐献卵子吗？

胚胎干细胞研究是目前生命科学领域中最热门的研究领域之一。但是，胚胎干细胞的来源却非常有限，特别是人类的胚胎干细胞，绝大部分都源自体外人工授精后未使用的胚胎；少部分是应用克隆技术制造的胚胎干细胞。但是，无论哪种途径，都离不开卵细胞。因此，要想获得足够的胚胎干细胞，就要有足够的卵子。世界闻名的韩国科学家黄禹锡的科学弊案，就包括逼迫女下属提供卵子。 为了胚胎干细胞的研究，是否可以提倡人们捐献卵子，对此，社会各界争论很大。     

胚胎干细胞中微小RNA功能与机制研究进展

胚胎干细胞自问世之初便承载了人们对于治疗各种疾病的期望。其来源于早期胚胎发育囊胚的内细胞团,这些细胞具有快速增殖和分化为所有其他体细胞的特性。由于这些特性,胚胎干细胞必须被小心加以控制才不至于在治疗过程中产生不受限制的生长(即致瘤性)和不必要的细胞污染。控制胚胎干细胞的增殖和分化的前提是人们尽可能多地掌握其内在调控的关键分子机制。对胚胎干细胞的增殖和分化的调控发生在多个层面,包括细胞信号通路、染色质高级结构、转录因子、微小RNA和长非编码RNA。简要综述胚胎干细胞中微小RNA的调控功能和机制研究进展,并展望这一领域未来的发展方向。     

胚胎干细胞技术的研究进展

干细胞可以分为成体干细胞和胚胎干细胞两类,是当前生物医学领域的一个热点。由于干细胞在医学领域有巨大应用前景,世界各国都对此给予了相当的重视;投入大量资金支持本国的科学家从事干细胞的科学研究。目前,干细胞的研究还处于试验室阶段,很多技术难题还没有解决,尤其是胚胎干细胞的不定向分化问题,以及一些伦理方面的争议。宗教界人士和社会论理学方面的人士对于干细胞的研究还有异议。集中论述了胚胎干细胞的研究进展和医学功用。     

RUSH and CRUSH: A rapid and conditional RNA interference method in mice

RNA interference (RNAi) is a powerful approach to phenocopy mutations in many organisms. Gold standard conventional knock‐out mouse technology is labor‐ and time‐intensive; however, off‐target effects may confound transgenic RNAi approaches. Here, we describe a rapid method for conditional and reversible gene silencing in RNAi transgenic mouse models and embryonic stem (ES) cells. RUSH and CRUSH RNAi vectors were designed for reversible or conditional knockdown, respectively, demonstrated using targeted replacement in an engineered ROSA26^lacZ ES cell line and wildtype V6.5 ES cells. RUSH was validated by reversible knockdown of Dnmt1 in vitro. Conditional mouse model production using CRUSH was expedited by deriving ES cell lines from Cre transgenic mouse strains (nestin, cTnnT, and Isl1) and generating all‐ES G₀ transgenic founders by tetraploid complementation. A control CRUSH^GFP RNAi mouse strain showed quantitative knockdown of GFP fluorescence as observed in compound CRUSH^GFP, Ds‐Red Cre‐reporter transgenic mice, and confirmed by Western blotting. The capability to turn RUSH and CRUSH alleles off or on using Cre recombinase enables this method to rapidly address questions of tissue‐specificity and cell autonomy of gene function in development. genesis 52:39–48, 2014. © 2013 Wiley Periodicals, Inc.     

A genetic screen for components of the mammalian RNA interference pathway in Bloom-deficient mouse embryonic stem cells

Genetic screens performed in model organisms have helped identify key components of the RNA interference (RNAi) pathway. Recessive genetic screens have recently become feasible through the use of mouse embryonic stem (ES) cells that are Bloom's syndrome protein (Blm) deficient. Here, we developed and performed a recessive genetic screen to identify components of the mammalian RNAi pathway in Blm-deficient ES cells. Genome-wide mutagenesis using a retroviral gene trap strategy resulted in the isolation of putative homozygous RNAi mutant cells. Candidate clones were confirmed by an independent RNAi-based reporter assay and the causative gene trap integration site was identified using molecular techniques. Our screen identified multiple mutant cell lines of Argonaute 2 (Ago2), a known essential component of the RNAi pathway. This result demonstrates that true RNAi components can be isolated by this screening strategy. Furthermore, Ago2 homozygous mutant ES cells provide a null genetic background to perform mutational analyses of the Ago2 protein. Using genetic rescue, we resolve an important controversy regarding the role of two phenylalanine residues in Ago2 activity.     

Small interfering RNA and gene silencing in transgenic mice and rats

After short duplexes of synthetic 21-23 nt RNAs (siRNA) were reported to be effective in silencing specific genes, a vector-based approach for siRNAs was demonstrated in mammalian cultured cell lines. However, the effect of RNA interference (RNAi) on various differentiated cells in live animals remains unknown. In this report, we demonstrate that transgenically supplied siRNA can silence ubiquitously expressed enhanced green fluorescent protein in every part of the mouse and rat body. These results suggest that transgenic RNAi could function as an alternative method of gene silencing by applying homologous recombination to embryonic stem (ES) cells, and should be successful even in species where ES cell lines remain unestablished.     

Rai14 (Retinoic Acid Induced Protein 14) Is Involved in Regulating F-Actin Dynamics at the Ectoplasmic Specialization in the Rat Testis*

Rai14 (retinoic acid induced protein 14) is an actin binding protein first identified in the liver, highly expressed in the placenta, the testis, and the eye. In the course of studying actin binding proteins that regulate the organization of actin filament bundles in the ectoplasmic specialization (ES), a testis-specific actin-rich adherens junction (AJ) type, Rai14 was shown to be one of the regulatory proteins at the ES. In the rat testis, Rai14 was found to be expressed by Sertoli and germ cells, structurally associated with actin and an actin cross-linking protein palladin. Its expression was the highest at the ES in the seminiferous epithelium of adult rat testes, most notably at the apical ES at the Sertoli-spermatid interface, and expressed stage-specifically during the epithelial cycle in stage VII-VIII tubules. However, Rai14 was also found at the basal ES near the basement membrane, associated with the blood-testis barrier (BTB) in stage VIII-IX tubules. A knockdown of Rai14 in Sertoli cells cultured in vitro by RNAi was found to perturb the Sertoli cell tight junction-permeability function in vitro, mediated by a disruption of F-actin, which in turn led to protein mis-localization at the Sertoli cell BTB. When Rai14 in the testis in vivo was knockdown by RNAi, defects in spermatid polarity and adhesion, as well as spermatid transport were noted mediated via changes in F-actin organization and mis-localization of proteins at the apical ES. In short, Rai14 is involved in the re-organization of actin filaments in Sertoli cells during the epithelial cycle, participating in conferring spermatid polarity and cell adhesion in the testis.     

Directing pluripotent cell differentiation using "diced RNA" in transient transfection

Embryonic stem (ES) and embryonic carcinoma (EC) cells are pluripotent and have the capacity to differentiate into many cell types. The ability to direct their differentiation should have considerable practical applications. Here, we first report the use of diced short interfering RNAi against Oct4 in a transient approach, to direct differentiation of ES towards the trophectoderm lineage. We then apply this approach to downregulate Smad4 in mouse P19 EC cells. We have found that this leads to an increase in the levels of Pax6 (a neuroectoderm marker), reduction in the levels of Brachyury (a mesoderm marker), and a 3-fold increase in the number of betaIII tubulin-positive colonies when these cells were allowed to differentiate. This indicates a redirection of cell fate towards the neuroectoderm lineage. Thus, transient RNAi could provide a valuable tool to direct pluripotent cells along specific pathways of differentiation while circumventing permanent genetic changes.